• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子途径与研究性靶向治疗在化脓性汗腺炎中的应用

Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.

机构信息

Department of Health Science, University of Catanzaro Magna Graecia, 88100 Catanzaro, Italy.

Department of Dermatology, University of Rome Tor Vergata, 00133 Rome, Italy.

出版信息

Int J Mol Sci. 2020 Nov 10;21(22):8436. doi: 10.3390/ijms21228436.

DOI:10.3390/ijms21228436
PMID:33182701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7696820/
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting areas with a high density of apocrine glands and characterized by subcutaneous nodules that may evolve into fistulas with pus secretion.

METHODS

The aim of this review is to investigate all current knowledge on cytokine regulation in the pathogenesis of HS. A systematic literature research using the words "cytokine", "interleukin", "pathway", and "hidradenitis suppurativa" was performed in PubMed/Medline and Scopus/Embase databases. A search of the clinicaltrials.gov website for interventional recruiting and completed trials including the term "hidradenitis suppurativa" was also performed up to August 2020. We will discuss the pathogenetic role of various cytokines in HS and potential therapeutic targets for this debilitating disease.

RESULTS

The pathophysiology underlying this complex condition has not been clearly defined. An upregulation of various cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin (IL)-1, IL-17, IL-23, and other molecules seems to be related to this inflammatory condition. Various cells, such as lymphocytes T Helper 1 and 17 and keratinocytes seem to be involved in the genesis of this condition.

CONCLUSIONS

Several future studies and clinical trials are necessary in order to have new knowledge about HS and to properly treat this complex condition.

摘要

背景

化脓性汗腺炎(HS)是一种慢性炎症性皮肤病,影响大汗腺密度高的区域,其特征为皮下结节,可能发展为带有脓液分泌的瘘管。

方法

本综述旨在研究细胞因子调节在 HS 发病机制中的所有现有知识。在 PubMed/Medline 和 Scopus/Embase 数据库中使用“cytokine”、“interleukin”、“pathway”和“hidradenitis suppurativa”等词进行了系统的文献检索。还在 clinicaltrials.gov 网站上搜索了包括“hidradenitis suppurativa”一词的正在招募的干预性研究和已完成的研究,截至 2020 年 8 月。我们将讨论各种细胞因子在 HS 中的发病机制作用以及这种使人衰弱的疾病的潜在治疗靶点。

结果

这种复杂疾病的病理生理学尚未明确界定。各种细胞因子(如肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1、IL-17、IL-23 等)的上调似乎与这种炎症状态有关。各种细胞,如辅助性 T 细胞 1 和 17 以及角质形成细胞,似乎参与了这种疾病的发生。

结论

为了更好地治疗这种复杂的疾病,需要进行更多的未来研究和临床试验,以便更好地了解 HS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902a/7696820/347d2563b94b/ijms-21-08436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902a/7696820/33d2af6c03ce/ijms-21-08436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902a/7696820/e2810da48061/ijms-21-08436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902a/7696820/347d2563b94b/ijms-21-08436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902a/7696820/33d2af6c03ce/ijms-21-08436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902a/7696820/e2810da48061/ijms-21-08436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902a/7696820/347d2563b94b/ijms-21-08436-g003.jpg

相似文献

1
Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.细胞因子途径与研究性靶向治疗在化脓性汗腺炎中的应用
Int J Mol Sci. 2020 Nov 10;21(22):8436. doi: 10.3390/ijms21228436.
2
Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.用于治疗化脓性汗腺炎的新型治疗方法和靶点。
Curr Pharm Biotechnol. 2021;22(1):59-72. doi: 10.2174/1389201021666200505100556.
3
Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.化脓性汗腺炎:将炎症途径整合到一个连贯的致病模型中的系统评价。
Front Immunol. 2018 Dec 14;9:2965. doi: 10.3389/fimmu.2018.02965. eCollection 2018.
4
A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.在化脓性汗腺炎中发现一种新的辅助性 T 细胞 17 细胞因子:白细胞介素-26 的抗菌和促炎作用。
Br J Dermatol. 2019 Nov;181(5):1038-1045. doi: 10.1111/bjd.17854. Epub 2019 Jun 23.
5
Hidradenitis suppurativa.化脓性汗腺炎。
Med Clin (Barc). 2024 Feb 23;162(4):182-189. doi: 10.1016/j.medcli.2023.09.018. Epub 2023 Nov 13.
6
The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.巨噬细胞在化脓性汗腺炎发病机制中的关键作用。
Inflamm Res. 2017 Nov;66(11):931-945. doi: 10.1007/s00011-017-1074-y. Epub 2017 Jun 27.
7
Hidradenitis suppurativa: the role of immune dysregulation.化脓性汗腺炎:免疫失调的作用。
Int J Dermatol. 2014 Oct;53(10):1186-96. doi: 10.1111/ijd.12550. Epub 2014 Jun 25.
8
Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.特应性皮炎、化脓性汗腺炎和白癜风的皮肤免疫及其失调。
Cell Cycle. 2020 Feb;19(3):257-267. doi: 10.1080/15384101.2019.1707455. Epub 2020 Jan 5.
9
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.在化脓性汗腺炎皮肤中,肿瘤坏死因子 (TNF)-α、白细胞介素 (IL)-1β 和 IL-10 的水平升高:针对 TNF-α 和 IL-1β 的基本原理。
Br J Dermatol. 2011 Jun;164(6):1292-8. doi: 10.1111/j.1365-2133.2011.10254.x. Epub 2011 May 17.
10
Brodalumab for severe hidradenitis suppurativa: a case of clinico-radiologic improvement and literature review.布罗达单抗治疗严重化脓性汗腺炎:临床-影像学改善病例及文献复习。
J Dermatolog Treat. 2023 Dec;34(1):2270091. doi: 10.1080/09546634.2023.2270091. Epub 2023 Oct 16.

引用本文的文献

1
Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons.胰高血糖素样肽-1受体激动剂的获益-风险评估:对皮肤科医生和整形外科医生的启示
Dermatol Ther (Heidelb). 2025 Sep 9. doi: 10.1007/s13555-025-01537-5.
2
Global Hidradenitis Suppurativa Epidemiology: Exploring Themes and Gaps beyond Europe, Australia, and the USA.全球化脓性汗腺炎流行病学:探索欧洲、澳大利亚和美国以外地区的研究主题与差距
Dermatology. 2025 Jul 7:1-12. doi: 10.1159/000542389.
3
The Microbiome in Hidradenitis Suppurativa Tunnels: A Systematic Review.

本文引用的文献

1
Aetiology and pathogenesis of hidradenitis suppurativa.化脓性汗腺炎的病因和发病机制。
Br J Dermatol. 2020 Dec;183(6):999-1010. doi: 10.1111/bjd.19556. Epub 2020 Oct 13.
2
Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches.使用透皮分析贴片对化脓性汗腺炎中细胞因子和抗菌肽水平进行无创评估。
Br J Dermatol. 2021 Feb;184(2):343-345. doi: 10.1111/bjd.19462. Epub 2020 Sep 16.
3
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
化脓性汗腺炎窦道中的微生物群:一项系统综述
Int J Dermatol. 2025 Oct;64(10):1802-1812. doi: 10.1111/ijd.17892. Epub 2025 Jun 17.
4
The Sebaceous Gland: A Key Player in the Balance Between Homeostasis and Inflammatory Skin Diseases.皮脂腺:维持体内平衡与炎症性皮肤病平衡的关键因素。
Cells. 2025 May 20;14(10):747. doi: 10.3390/cells14100747.
5
A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment.一项关于肿瘤坏死因子-α阻滞剂、抗白细胞介素和小分子抑制剂用于治疗头皮蜂窝织炎的系统评价。
Orphanet J Rare Dis. 2025 May 18;20(1):236. doi: 10.1186/s13023-025-03720-5.
6
Hidradenitis suppurativa, from basic science to surgery and a new era of tailored targeted therapy: An expert opinion paper.化脓性汗腺炎:从基础科学到外科手术及量身定制的靶向治疗新时代:一篇专家意见论文
Arch Dermatol Res. 2025 Feb 28;317(1):511. doi: 10.1007/s00403-025-04016-1.
7
Integrative systems biology framework discovers common gene regulatory signatures in mechanistically distinct inflammatory skin diseases.整合系统生物学框架在机制上不同的炎症性皮肤病中发现了共同的基因调控特征。
NPJ Syst Biol Appl. 2025 Feb 27;11(1):21. doi: 10.1038/s41540-025-00498-x.
8
Beyond the skin: endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa.超越皮肤层面:化脓性汗腺炎女性患者的内分泌、心理及营养方面
J Transl Med. 2025 Feb 10;23(1):167. doi: 10.1186/s12967-025-06175-1.
9
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).化脓性汗腺炎中与阿达木单抗治疗反应相关的因素:来自欧洲化脓性汗腺炎注册中心比利时患者(ERHS-Be)的证据。
Arch Dermatol Res. 2025 Jan 7;317(1):189. doi: 10.1007/s00403-024-03675-w.
10
Unlocking the Mechanisms of Hidradenitis Suppurativa: Inflammation and miRNA Insights.揭开化脓性汗腺炎的发病机制:炎症与微小RNA的见解
Clin Cosmet Investig Dermatol. 2024 Dec 11;17:2829-2846. doi: 10.2147/CCID.S483871. eCollection 2024.
白细胞介素-1(IL-1)在 COVID-19 中诱导血栓烷 A2(TxA2)的产生,导致炎症和微血栓形成:白细胞介素-1 受体拮抗剂(IL-1Ra)的抑制作用。
J Biol Regul Homeost Agents. 2020;34(5):1623-1627. doi: 10.23812/20-34-4EDIT-65.
4
Effectiveness of ustekinumab for moderate-to-severe hidradenitis suppurativa: a case series.乌司奴单抗治疗中重度化脓性汗腺炎的有效性:病例系列研究
J Dermatolog Treat. 2022 Mar;33(2):1159-1162. doi: 10.1080/09546634.2020.1776208. Epub 2020 Jun 11.
5
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study.皮下注射布罗达umab 对化脓性汗腺炎临床疾病活动的影响:一项开放性队列研究。
J Am Acad Dermatol. 2020 Nov;83(5):1341-1348. doi: 10.1016/j.jaad.2020.05.007. Epub 2020 May 13.
6
Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice.化脓性汗腺炎的医学和手术治疗:国际治疗指南综述及在普通皮肤科实践中的应用。
Dermatology. 2020;236(5):393-412. doi: 10.1159/000507323. Epub 2020 May 14.
7
The pharmacology of antibiotic therapy in hidradenitis suppurativa.在化脓性汗腺炎的抗生素治疗中的药理学。
Expert Rev Clin Pharmacol. 2020 May;13(5):521-530. doi: 10.1080/17512433.2020.1762571. Epub 2020 Jul 7.
8
Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review.乌司奴单抗治疗化脓性汗腺炎患者:多中心病例系列和系统评价。
J Dermatolog Treat. 2022 Feb;33(1):348-353. doi: 10.1080/09546634.2020.1755008. Epub 2020 Apr 21.
9
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.如何降低冠状病毒-19(CoV-19 或 SARS-CoV-2)感染和白细胞介素-1(IL-1)介导的肺部炎症的可能性。
J Biol Regul Homeost Agents. 2020;34(2):333-338. doi: 10.23812/Editorial-Conti-2.
10
Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.化脓性汗腺炎:对发病机制的当前认识及治疗方案建议
Front Med (Lausanne). 2020 Mar 4;7:68. doi: 10.3389/fmed.2020.00068. eCollection 2020.